IMMEDIATE NOTIFICATION OF PUBLIC HEALTH AUTHORITIES
Vaccine administered up to 3 days post-exposure was effective in preventing infection as well as lessening the severity of the disease if infection occurred 
Vaccinia Vaccine (administer within 72hrs of exposure)
Supportive care and wound care for open lesions
Vaccinia Vaccine within the first 72hrs can decrease total disease severity and within 7 days may decrease symptoms
Vaccination is not efficacious once the patient has developed rash
Vaccination is not efficacious once the patient has developed rash
Contraindications for administration include:
Pregnancy
Severe cardiac disease
Immunocompromise
Same living quarters as other person with above contraindications
due to viral shedding
due to viral shedding
Airborne and contact isolation with negative pressure
Personal protective wear level D with N95 respirator
Smallpox
Atopic dermatitis
Tularemia
Bed bugs
Scabies
Contact dermatitis
Measles
Drug rash